HOUSE . . . . . . . . No. 4392
|
The Commonwealth of Massachusetts
________________________________________
HOUSE OF REPRESENTATIVES, February 15, 2024.
The committee on Children, Families and Persons with Disabilities, to whom were referred the petition (accompanied by bill, Senate, No. 64) of Joanne M. Comerford and Jason M. Lewis for legislation to support families, the petition (accompanied by bill, Senate, No. 129) of John C. Velis for legislation relative to medication-assisted treatment, the petition (accompanied by bill, House, No. 166) of Carole A. Fiola and others relative to substance exposed newborns and the petition (accompanied by bill, House, No. 173) of Sean Garballey and others for legislation to protect infants affected by in-utero substance exposure or fetal alcohol spectrum disorder, reports recommending that the accompanying bill (House, No. 4392) ought to pass [Representatives Berthiaume of Spencer and Sullivan-Almeida of Abington dissent].
For the committee,
JAY D. LIVINGSTONE.
FILED ON: 2/7/2024
HOUSE . . . . . . . . . . . . . . . No. 4392
|
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act relative to substance exposed newborns.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Section 51A of chapter 119 of the general laws is hereby amended in subsection (a) in the first paragraph by striking out the words:-
(iii) physical dependence upon an addictive drug at birth,
SECTION 2. Said section 51A is hereby further amended by inserting after subsection (a) the following new subsection:-
(a ½) An indication of prenatal substance exposure does not, in of itself, meet the requirements of subsection (a). The Department of Public Health shall promulgate regulations and guidance in consultation with the Department of Children and Families under Section 51L of Chapter 111 of the general laws as to how substance exposure shall be weighed in determining whether to file a report, including any instances in which prenatal substance exposure from a medication prescribed by a licensed healthcare provider may be considered in filing a report.
SECTION 3. Chapter 111 of the general laws is hereby amended by inserting in Section 1 the following:
“Plan of Safe Care”, a family care plan designed to ensure the safety and well-being of an infant with prenatal substance exposure following his or her release from the care of a healthcare provider by addressing the health and substance use treatment needs of the infant and affected family or caregiver.
SECTION 4: Chapter 111 of the general laws is hereby amended by inserting after section 51K the following section:-
Section 51L. (a) The Department of Public Health in consultation with the Department of Children and Families shall promulgate regulations and corresponding guidance for all healthcare providers who care for perinatal patients and/or newborns detailing the roles and responsibilities of staff related to the requirement that healthcare providers must:
(1) Screen for prenatal substance exposure using a validated questionnaire and provide brief intervention, treatment initiation, and referral as clinically indicated;
(2) Notify the Department of Public Health of all births of infants who were prenatally exposed to substances pursuant to the requirements of the federal Child Abuse Prevention and Treatment Act and the protocols described in this section;
(3) Prior to postnatal discharge, determine whether to file a report of suspected child abuse or neglect as required by section 51A of chapter 119 and identify if a plan of safe care, as defined in section 1 of chapter 111, has been developed;
(4) Assess family needs, develop a plan of safe care if indicated, and refer families to appropriate services, as directed by the Department of Public Health and pursuant to the federal Child Abuse Prevention and Treatment Act.
(b) The Department of Public Health shall develop a plan to receive notifications of substance exposed births, as defined in regulation under subsection (a) of this section, directly from healthcare providers and shall collect data for reporting in a manner that is in compliance with the federal Child Abuse Prevention and Treatment Act.
(c) The Department of Public Health shall establish a program to ensure perinatal individuals, families, and providers have access to services designed to support the development and implementation of an effective plan of safe care, including services addressing the health and substance use disorder treatment needs of the infants and affected family or caregivers, as required by the federal Child Abuse Prevention and Treatment Act. Said program shall include a central system perinatal individuals, families and providers can contact to receive information and referrals, as well as a system of community-based services to meet the behavioral health, parenting, and child development needs of families affected by substance use and substance use disorders, subject to appropriation.
(d) The Department of Children and Families shall provide, and the Department of Public Health shall receive, submissions of data from the Department of Children and Families to the Public Health Data Warehouse in order to facilitate ongoing quality assurance and evaluation projects related to this statute and other family-service initiatives.
(e) The Department of Public Health shall provide date to the Department of Children and Families on all births of infants who were prenatally exposed to substances in a form and manner that is complaint with the requirements of the federal Child Abuse Prevention and Treatment Act, provided that said data shall not include personally identifiable information.
(f) There may be a multidisciplinary standing committee established for the purpose of advising the Department of Public Health in matters related to prenatal substance exposure, maternal and child health, treatment of substance use disorder, and racial equity in access to healthcare, and includes at least one child focused professional. This advisory committee shall consist of seven persons appointed by the governor with one representative from each of the following organizations: the Massachusetts Medical Society, the Massachusetts Health and Hospital Association, Massachusetts Organization for Addiction Recovery, the Massachusetts branches of the National Association for the Advancement of Colored People New England Area Conference, the Massachusetts chapter of the National Association of Social Workers, the Committee for Public Counsel Services, and the Massachusetts chapter of the American Congress of Obstetricians and Gynecologists. The committee shall make recommendations to the Department of Public Health, based on research and analysis, to ensure that all regulations: (i) reflect current accepted standards of healthcare and substance use treatment practices; (ii) conform to the reporting requirements under the federal Child Abuse Prevention and Treatment Act; and (iii) do not create racial disparities in maternal and child healthcare, reports of suspected child abuse or neglect under section 51A of chapter 119, or number of patients identified for plans of safe care as defined in section 1 of chapter 111.
SECTION 5. (a) The department of the children and families, in consultation with the department of public health and the office of the child advocate, shall develop a report to study the impact of this legislation on child and family safety and well-being. The departments shall consider:
(1) Any impact, positive or negative, the changes may have had on racial and ethnic disparities;
(2) Any impact the statutory changes may have had on child safety;
(3) Any impact the statutory changes may have had on child well-being;
(4) Gaps in infant and parent services; and
(5) Any additional statutory or regulatory changes that may be needed.
(b) The report shall include, but not be limited to:
(1) An examination of child abuse and neglect reports related to an infant’s exposure at birth to substances, including those that were ultimately screened out by the department of children and families;
(2) An examination of longitudinal custodial, developmental, and service provision outcomes of infants who were reported to be exposed to substances at birth that did not result in a child abuse and neglect report;
(3) An examination of child abuse and neglect reports made under Section 51A of chapter 119 related to an infant’s exposure at birth to substances;
(4) The demographics, including race and ethnicity, of both the child and the parents that are the subject of reports described in clauses (1) through (3).
(c) If feasible, said report shall include relevant aggregate quantitative data on all cases that meet the criteria specified in subsection (b)(1) and (b)(2) above, as well as a qualitative analysis that includes a review of case notes in the database maintained by the department of children and families for a sample of cases.
(d) No later than 18 months after the effective date of this legislation the department of children and families, shall file an interim report of its findings with the clerks of the senate and house of representatives, the senate committee on ways and means, the house committee on ways and means, the joint committee on children, families, and person with disabilities, and the joint committee on mental health, substance use and recovery.
(e) No later than three years after the effective date of this legislation, the department of children and families shall file a final report of its findings with the clerks of the senate and house of representatives, the senate committee on ways and means, the house committee on ways and means, the joint committee on children, families, and person with disabilities, and the joint committee on mental health, substance use and recovery.
SECTION 6. Sections 1 and 2 shall be effective eighteen months after the passage of this legislation.
SECTION 7. Sections 3 and 4 shall be implemented and effective twelve months after the passage of this legislation.